134 related articles for article (PubMed ID: 11967501)
1. Nitric oxide induced cervical ripening in the human: Involvement of cyclic guanosine monophosphate, prostaglandin F(2 alpha), and prostaglandin E(2).
Ekerhovd E; Weijdegård B; Brännström M; Mattsby-Baltzer I; Norström A
Am J Obstet Gynecol; 2002 Apr; 186(4):745-50. PubMed ID: 11967501
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide donors stimulate prostaglandin F(2alpha) and inhibit thromboxane B(2) production in the human cervix during the first trimester of pregnancy.
Ledingham MA; Denison FC; Kelly RW; Young A; Norman JE
Mol Hum Reprod; 1999 Oct; 5(10):973-82. PubMed ID: 10508227
[TBL] [Abstract][Full Text] [Related]
3. Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy.
Thomson AJ; Lunan CB; Ledingham M; Howat RC; Cameron IT; Greer IA; Norman JE
Lancet; 1998 Oct; 352(9134):1093-6. PubMed ID: 9798584
[TBL] [Abstract][Full Text] [Related]
4. Isosorbide mononitrate induces increased cervical expression of cyclooxygenase-2, but not of cyclooxygenase-1, at term.
Bullarbo M; Norström A; Andersch B; Ekerhovd E
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):160-4. PubMed ID: 16675095
[TBL] [Abstract][Full Text] [Related]
5. Outpatient cervical ripening before first-trimester surgical abortion: a comparison between misoprostol and isosorbide mononitrate.
Radulovic N; Norström A; Ekerhovd E
Acta Obstet Gynecol Scand; 2007; 86(3):344-8. PubMed ID: 17364311
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the efficacy of outpatient use of isosorbide mononitrate on cervical ripening in pregnant women with unfavourable cervix.
Kashanian M; Jangjoo S; Sheikhansari N; KaramiAbd T
J Obstet Gynaecol; 2021 Aug; 41(6):876-880. PubMed ID: 33225782
[TBL] [Abstract][Full Text] [Related]
7. The "PRIM" study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term.
Osman I; MacKenzie F; Norrie J; Murray HM; Greer IA; Norman JE
Am J Obstet Gynecol; 2006 Apr; 194(4):1012-21. PubMed ID: 16580290
[TBL] [Abstract][Full Text] [Related]
8. A comparison of isosorbide mononitrate, misoprostol and combination therapy for first trimester pre-operative cervical ripening: a randomised controlled trial.
Ledingham MA; Thomson AJ; Lunan CB; Greer IA; Norman JE
BJOG; 2001 Mar; 108(3):276-80. PubMed ID: 11281468
[TBL] [Abstract][Full Text] [Related]
9. Intracervical application of the nitric oxide donor isosorbide dinitrate for induction of cervical ripening: a randomised controlled trial to determine clinical efficacy and safety prior to first trimester surgical evacuation of retained products of conception.
Arteaga-Troncoso G; Villegas-Alvarado A; Belmont-Gomez A; Martinez-Herrera FJ; Villagrana-Zesati R; Guerra-Infante F
BJOG; 2005 Dec; 112(12):1615-9. PubMed ID: 16305563
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide donors induce ripening of the human uterine cervix: a randomised controlled trial.
Thomson AJ; Lunan CB; Cameron AD; Cameron IT; Greer IA; Norman JE
Br J Obstet Gynaecol; 1997 Sep; 104(9):1054-7. PubMed ID: 9307534
[TBL] [Abstract][Full Text] [Related]
11. Vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening at term: a randomized controlled study.
Ekerhovd E; Bullarbo M; Andersch B; Norström A
Am J Obstet Gynecol; 2003 Dec; 189(6):1692-7. PubMed ID: 14710100
[TBL] [Abstract][Full Text] [Related]
12. Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study.
Bullarbo M; Orrskog ME; Andersch B; Granström L; Norström A; Ekerhovd E
Am J Obstet Gynecol; 2007 Jan; 196(1):50.e1-5. PubMed ID: 17240231
[TBL] [Abstract][Full Text] [Related]
13. Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics.
Nicoll AE; Mackenzie F; Greer IA; Norman JE
Am J Obstet Gynecol; 2001 Apr; 184(5):958-64. PubMed ID: 11303205
[TBL] [Abstract][Full Text] [Related]
14. Serum profile of isosorbide mononitrate after vaginal administration in the third trimester.
Bates CD; Nicoll AE; Mullen AB; Mackenzie F; Thomson AJ; Norman JE
BJOG; 2003 Jan; 110(1):64-7. PubMed ID: 12504938
[TBL] [Abstract][Full Text] [Related]
15. Cervical priming in the first trimester: morphological and biochemical effects of misoprostol and isosorbide mononitrate.
Radulovic NV; Ekerhovd E; Abrahamsson G; Norstrom A
Acta Obstet Gynecol Scand; 2009; 88(1):43-51. PubMed ID: 19034732
[TBL] [Abstract][Full Text] [Related]
16. Outpatient cervical ripening with nitric oxide donor isosorbide mononitrate prior to induction of labor.
Habib SM; Emam SS; Saber AS
Int J Gynaecol Obstet; 2008 Apr; 101(1):57-61. PubMed ID: 18222450
[TBL] [Abstract][Full Text] [Related]
17. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial.
Schmitz T; Fuchs F; Closset E; Rozenberg P; Winer N; Perrotin F; Verspyck E; Azria E; Carbonne B; Lepercq J; Maillard F; Goffinet F;
Obstet Gynecol; 2014 Dec; 124(6):1089-1097. PubMed ID: 25415159
[TBL] [Abstract][Full Text] [Related]
18. Interruption of a study of cervical ripening with isosorbide mononitrate due to adverse effects.
Hatanaka AR; Moron AF; Auxiliadora de Aquino MM; de Souza E; de Silva Bussamra LC; Araujo Júnior E; Mattar R
Clin Exp Obstet Gynecol; 2012; 39(2):175-80. PubMed ID: 22905458
[TBL] [Abstract][Full Text] [Related]
19. Isosorbide-5-mononitrate treatment prevents cyclosporin A-induced platelet hyperactivation and the underlying nitric oxide-cyclic guanosine-3',5'-monophosphate disturbances.
Reis F; Almeida L; Alcobia T; Santos-Dias JD; Lourenço M; Palmeiro A; Ferrer-Antunes CA; Mesquita JF; Pontes F; Teixeira F
Thromb Res; 2003 May; 110(2-3):107-15. PubMed ID: 12893025
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide donor isosorbide mononitrate for pre-induction cervical ripening at 41 weeks' gestation: A randomized controlled trial.
Rameez MF; Goonewardene IM
J Obstet Gynaecol Res; 2007 Aug; 33(4):452-6. PubMed ID: 17688611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
